Welcome To Welox Pharma WHO-GMP | ISO 9001:2015

+91 7984303039 inquiry@weloxpharma.com
Translated into: English Spanish Portuguese French
+91 7984303039 inquiry@weloxpharma.com

Category

Show more...

Amgicin 200 Gemcitabine Injection IP 200 Mg

  • Product Name : Amgicin 200 Gemcitabine Injection IP 200 Mg
  • Category : Anti Cancer
  • Manufacturer Name : Adley
  • Trade Name : Amgicin 200
  • Available Dosage : 200 mg
  • Packing : Vial
  • Pack Insert/Leaflet : 1 Vial/200 Mg
  • Ingredients : Gemcitabine
  • Formulation : Injection
  • Therapeutic use : to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer
  • Production Capacity : 100000

Description:-

Introduction to Amgicin 200 Gemcitabine Injection IP

Amgicin 200 Gemcitabine Injection IP is a chemotherapy drug used to treat a variety of cancers. Gemcitabine, an antimetabolite, disrupts the growth and spread of cancer cells, offering an effective treatment option under medical supervision.


Uses of Amgicin 200 Gemcitabine Injection IP

Treats non-small cell lung cancer

Manages pancreatic cancer

Effective for bladder cancer treatment

Used in breast cancer therapy

Treats ovarian cancer


Benefits of Amgicin 200 Gemcitabine Injection IP

Provides effective treatment for various cancers

Slows the progression of cancer

Well-researched and extensively used in oncology

Can be administered alone or with other chemotherapy agents


Mechanism of Action of Amgicin 200 Gemcitabine Injection IP

Gemcitabine interferes with DNA synthesis by mimicking nucleotides, inhibiting cell division and inducing apoptosis in cancer cells. This antimetabolite action prevents the growth and spread of cancer, aiding in effective cancer treatment.